Nasdaq
$28.73▼ 0.17%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.68BShares out 58.6M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
56- 2d agoAfter-hours26.10.23 05:264Ownership#●●●
KESTRA MEDICAL TECHNOLOGIES, LTD.
Insider Traci S. Umberger of KESTRA MEDICAL TECHNOLOGIES, LTD. filed a Form 4 statement of changes in beneficial ownership of securities on October 21, 2026. This filing officially reports the changes in the insider's stock holdings to the SEC.…more
$28.73-0.17%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 2d agoAfter-hours26.10.23 05:244Ownership
KESTRA MEDICAL TECHNOLOGIES, LTD.
Insider Brian Daniel Webster of KESTRA MEDICAL TECHNOLOGIES, LTD. reported a change in beneficial ownership of securities effective October 20, 2026. This filing serves as a formal disclosure of insider equity movement via Form 4.…more
$28.73-0.17%vs prev closeView filingShare - 3d agoAfter-hours26.10.22 05:01144Ownership
KESTRA MEDICAL TECHNOLOGIES, LTD.
KESTRA MEDICAL TECHNOLOGIES, LTD. insider Traci S. Umberger has filed an SEC Form 144 to report the proposed sale of company shares. This is a standard filing disclosing the insider's plan to dispose of their holdings.…more
$28.73-0.17%vs prev closeView filingShare
55 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.1Pre-market26.10.01 19:00#●●●
Kestra Medical Earns Five-Star Rating on Newsweek’s Greatest Mid-Market Companies List…more
Kestra Medical Technologies has been awarded a five-star rating on Newsweek’s 2026 list of America’s Greatest Mid-Market Companies. The company was the only honoree in the medical equipment manufacturing category to receive this top rating based on financial performance and innovation.…more
$28.73-0.17%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.14After-hours26.09.15 05:01
●●●●●●●● ●●●●● ●●●●●●
Kestra Medical has increased its FY2027 sales outlook to $141 million from the previous $137 million. This revised guidance exceeds the market consensus estimate of $137.023 million.…more
$28.73-0.17%vs prev closeShareBenzinga - 9.10Pre-market26.09.10 19:00
●●●●●●●● ●●●●● ●●●●●●
Kestra Medical Technologies has appointed Daniel Finney as its new Vice President of Research & Development to join the executive leadership team. This leadership change aims to accelerate the development of the company's wearable cardiac protection platform and integrate AI-driven innovations.…more
$28.73-0.17%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report